Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-12-19 4:40 pm Purchase | 2025-12-18 | 13G | Vor Biopharma Inc. VOR | Frazier Life Sciences Public Fund, L.P. | 2,258,001 5.800% | 2,258,001 (New Position) | Filing History |
| 2025-12-16 4:39 pm Purchase | 2025-12-09 | 13G | iBio, Inc. IBIO | Frazier Life Sciences Public Fund, L.P. | 1,953,467 8.700% | 1,953,467 (New Position) | Filing History |
| 2025-12-09 5:31 pm Sale | 2025-12-09 | 13G | Adverum Biotechnologies, Inc. ADVM | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -4,288,949 (Position Closed) | Filing History |
| 2025-11-28 3:25 pm Purchase | 2025-11-25 | 13G | Adverum Biotechnologies, Inc. ADVM | Frazier Life Sciences Public Fund, L.P. | 4,288,949 19.400% | 3,159,892 (+279.87%) | Filing History |
| 2025-11-14 4:29 pm Sale | 2025-09-30 | 13G | Trevi Therapeutics, Inc. TRVI | Frazier Life Sciences Public Fund, L.P. | 8,508,021 7.000% | -1,751,388 (-17.07%) | Filing History |
| 2025-11-14 4:28 pm Purchase | 2025-09-30 | 13G | Jade Biosciences, Inc. JBIO | Frazier Life Sciences Public Fund, L.P. | 1,384,646 4.200% | 43,943 (+3.28%) | Filing History |
| 2025-11-04 5:24 pm Unchanged | 2025-11-01 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 5,985,327 8.600% | 0 (Unchanged) | Filing History |
| 2025-11-04 5:21 pm Purchase | 2025-11-01 | 13D | KalVista Pharmaceuticals, Inc. KALV | Frazier Life Sciences Public Fund, L.P. | 3,466,521 6.900% | 1,066,245 (+44.42%) | Filing History |
| 2025-09-30 5:01 pm Purchase | 2025-09-26 | 13D | MBX Biosciences, Inc. Common Stock MBX | Frazier Life Sciences Public Fund, L.P. | 5,224,095 11.700% | 666,998 (+14.64%) | Filing History |
| 2025-09-17 5:21 pm Sale | 2025-09-17 | 13D | HilleVax, Inc. HLVX | Frazier Life Sciences Public Fund, L.P. | 0 0.000% | -10,639,562 (Position Closed) | Filing History |
| 2025-08-20 5:23 pm Sale | 2025-08-18 | 13D | MBX Biosciences, Inc. Common Stock MBX | Frazier Life Sciences Public Fund, L.P. | 4,557,097 13.600% | -1,428,250 (-23.86%) | Filing History |
| 2025-08-20 5:20 pm Sale | 2025-08-18 | 13D | KalVista Pharmaceuticals, Inc. KALV | Frazier Life Sciences Public Fund, L.P. | 2,400,276 4.800% | -2,487,591 (-50.89%) | Filing History |
| 2025-08-20 5:18 pm Sale | 2025-08-18 | 13D | Phathom Pharmaceuticals, Inc. PHAT | Frazier Life Sciences Public Fund, L.P. | 5,985,327 8.600% | -8,444,663 (-58.52%) | Filing History |
| 2025-08-14 1:47 pm Purchase | 2025-06-30 | 13G | Xilio Therapeutics, Inc. XLO | Frazier Life Sciences Public Fund, L.P. | 8,141,017 9.900% | 2,393,824 (+41.65%) | Filing History |
| 2025-08-14 1:46 pm Sale | 2025-06-30 | 13G | Jade Biosciences, Inc. JBIO | Frazier Life Sciences Public Fund, L.P. | 1,340,703 4.200% | -431,413 (-24.34%) | Filing History |
| 2025-08-14 1:44 pm Sale | 2025-06-30 | 13G | Aura Biosciences, Inc. AURA | Frazier Life Sciences Public Fund, L.P. | 3,113,550 5.000% | -3,202,128 (-50.70%) | Filing History |
| 2025-08-14 1:43 pm Sale | 2025-06-30 | 13G | Maze Therapeutics, Inc. MAZE | Frazier Life Sciences Public Fund, L.P. | 3,352,915 7.700% | -1,098,424 (-24.68%) | Filing History |
| 2025-08-14 1:41 pm Sale | 2025-06-30 | 13G | Palvella Therapeutics, Inc. PVLA | Frazier Life Sciences Public Fund, L.P. | 545,504 4.900% | -144,508 (-20.94%) | Filing History |
| 2025-08-14 1:40 pm Sale | 2025-06-30 | 13G | Lexeo Therapeutics, Inc. Common Stock LXEO | Frazier Life Sciences Public Fund, L.P. | 3,073,467 5.700% | -2,427,345 (-44.13%) | Filing History |
| 2025-08-14 1:39 pm Sale | 2025-06-30 | 13G | Mereo BioPharma Group plc MREO | Frazier Life Sciences Public Fund, L.P. | 32,430,690 4.100% | -7,918,625 (-19.63%) | Filing History |